Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?

[1]  M. Katashima,et al.  Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[2]  Godfrey L. Smith,et al.  Negative Inotropy of the Gastric Proton Pump Inhibitor Pantoprazole in Myocardium From Humans and Rabbits: Evaluation of Mechanisms , 2007, Circulation.

[3]  P. Mitchell,et al.  Low hemoglobin, chronic kidney disease, and risk for coronary heart disease-related death: the Blue Mountains Eye Study. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  T. Sakata,et al.  H2-Blocker modulates heart rate variability , 2006, Heart and Vessels.

[5]  B. Gersh.  Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents , 2006 .

[6]  R. Onur,et al.  Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium. , 2005, European journal of pharmacology.

[7]  Patrick W Serruys,et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy , 2004, The Lancet.

[8]  K. Sugano.  [Japanese guideline for the management of gastric ulcer]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[9]  日本循環器学会.  循環器疾患における抗凝固・抗血小板療法に関するガイドライン(JCS2004) , 2004 .

[10]  M. Schulz,et al.  Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. , 2003, Die Pharmazie.

[11]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.

[12]  Sankey V. Williams,et al.  ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Journal of the American College of Cardiology.

[13]  D. Graham,et al.  Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. , 2002, Archives of internal medicine.

[14]  W. Kirch,et al.  Clinical Aspects of Cardiovascular Effects of H2‐Receptor Antagonists , 1995, Journal of clinical pharmacology.

[15]  A. Halabi,et al.  Cardiovascular effects of omeprazole and famotidine. , 1992, Scandinavian journal of gastroenterology.

[16]  H. Dodge,et al.  The use of biplane angiocardigraphy for the measurement of left ventricular volume in man. , 1960, American heart journal.